I agree that this site is using cookies. You can find further informations here.
X
Talbot, George H.
1347  results:
Search for persons X
?
1

Understanding Early and Late Endpoints in Registrational Tr..:

Talbot, George H
Clinical Infectious Diseases.  73 (2020)  9 - p. e2613-e2615 , 2020
Link: https://doi.org/10.1093/..
 
?
2

Widening the Overton Window—While Avoiding Defenestration:

Talbot, George H
Clinical Infectious Diseases.  70 (2019)  11 - p. 2442-2443 , 2019
Link: https://doi.org/10.1093/..
 
?
3

Erratum to: Efficacy and Safety of Intravenous-to-oral Lefa..:

Gasink, Leanne B ; Talbot, George H ; Wicha, Wolfgang W...
Clinical Infectious Diseases.  70 (2019)  11 - p. 2459-2459 , 2019
Link: https://doi.org/10.1093/..
 
?
4

Efficacy and Safety of Intravenous-to-oral Lefamulin, a Ple..:

File Jr, Thomas M ; Goldberg, Lisa ; Das, Anita...
Clinical Infectious Diseases.  69 (2019)  11 - p. 1856-1867 , 2019
Link: https://doi.org/10.1093/..
 
?
5

Evidence-Based Study Design for Hospital-Acquired Bacterial..:

Talbot, George H ; Das, Anita ; Cush, Stephanie...
The Journal of Infectious Diseases.  219 (2019)  10 - p. 1536-1544 , 2019
Link: https://doi.org/10.1093/..
 
?
6

Elaboration of Consensus Clinical Endpoints to Evaluate Ant..:

Weiss, Emmanuel ; Zahar, Jean-Ralph ; Alder, Jeff...
Clinical Infectious Diseases.  69 (2019)  11 - p. 1912-1918 , 2019
Link: https://doi.org/10.1093/..
 
?
7

The Infectious Diseases Society of America's 10 × '20 Initi..:

Talbot, George H ; Jezek, Amanda ; Murray, Barbara E...
Clinical Infectious Diseases.  69 (2019)  1 - p. 1-11 , 2019
Link: https://doi.org/10.1093/..
 
?
8

Clostridium difficile Infection–Daily Symptoms (CDI-DaySyms..:

Talbot, George H. ; Kleinman, Leah ; Davies, Evan...
Health and Quality of Life Outcomes.  17 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
9

2386. Efficacy of Lefamulin (LEF) vs. Moxifloxacin (MOX) Ag..:

File, Thomas ; Goldberg, Lisa ; Paukner, Susanne...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S711-S712 , 2018
Link: https://doi.org/10.1093/..
 
?
10

The CDI-DaySyms: Content Development of a New Patient-Repor..:

Kleinman, Leah ; Talbot, George H. ; Hunsche, Elke..
Value in Health.  21 (2018)  4 - p. 441-448 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Macrolide therapy for community-acquired pneumonia due to a..:

File Jr, Thomas M. ; Eckburg, Paul B. ; Talbot, George H...
International Journal of Antimicrobial Agents.  50 (2017)  2 - p. 247-251 , 2017
Link: https://doi.org/10.1016/..
 
?
12

The Clostridium difficile Infection – Daily Symptoms (CDI-D..:

Talbot, George H ; Kleinman, Leah ; Davies, Evan W...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S394-S394 , 2017
Link: https://doi.org/10.1093/..
 
?
13

Progress in the Fight Against Multidrug-Resistant Bacteria ..:

Rex, John H ; Talbot, George H ; Goldberger, Mark J...
Clinical Infectious Diseases.  65 (2017)  1 - p. 141-146 , 2017
Link: https://doi.org/10.1093/..
 
?
14

Progress in the Fight Against Multidrug-Resistant Bacteria ..:

Rex, John H. ; Talbot, George H. ; Goldberger, Mark J....
Clinical Infectious Diseases.  65 (2017)  1 - p. 141-146 , 2017
Link: https://www.jstor.org/st..
 
?
15

Developing Outcomes Assessments as Endpoints for Registrati..:

Talbot, George H. ; Powers, John H. ; Hoffmann, Steven C.
Clinical Infectious Diseases.  62 (2016)  5 - p. 603-607 , 2016
Link: https://www.jstor.org/st..
 
1-15